Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential
Endocrine Reviews · 2026
DOI: 10.1210/endrev/bnaf043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, 2026. Verfasst von Michał Ciebiera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, Warsaw Institute of Women's Health, Warsaw 00-189, Poland. Hauptthemen laut MEDLINE: Leiomyoma, Vitamin D, Uterine Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Center of Postgraduate Medical Education, National Institute of Health.
Abstract (Originalsprache)
Uterine fibroids (UFs) are highly prevalent benign tumors, primarily affecting women of reproductive age. The prevalence of UFs is estimated at 25% to 70% to 80%, with significantly higher rates among African women. Recent investigations have unveiled a link between vitamin D (VD) levels and the presence of UFs. Current data show that individuals with sufficient VD levels are at a reduced risk of developing UFs. This review aims to synthesize the latest discoveries on the involvement of VD in the pathophysiology of UFs, as well as to explore its feasible therapeutic applications. The mechanisms underlying the potential of VD to diminish the risk of UF development and to inhibit their growth are multifaceted and include its antiproliferative effects, the induction of apoptosis, suppression of angiogenesis, or the modulation of enzyme activity. The potential of VD and its analogues as promising agents for managing and preventing UFs was demonstrated. However, further research is needed to clarify the biological mechanisms behind the role of VD in UF pathophysiology, and its definitive efficacy has to be confirmed through randomized clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, Warsaw Institute of Women's Health, Warsaw 00-189, Poland.
- Warsaw Institute of Women's Health, Warsaw 00-189, Poland.
- Development and Research Center of Non-Invasive Therapies, Pro-Familia Hospital, Rzeszów 35-302, Poland.
- Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw 02-781, Poland.
- Department of Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland.
- Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, Warsaw 01-809, Poland.
ORCID-Profile: Elżbieta Zarychta
Förderung
- Center of Postgraduate Medical Education
- National Institute of Health
Zitieren
APA
Ciebiera, M., Zarychta, E., Żeber-Lubecka, N., Zgliczyńska, M., Włodarczyk, M., Massalska, D., Corachán, A., Ali, M., Madueke-Laveaux, O. S., & Al-Hendy, A. (2026). Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential. Endocrine Reviews. https://doi.org/10.1210/endrev/bnaf043
Vancouver
Ciebiera M, Zarychta E, Żeber-Lubecka N, Zgliczyńska M, Włodarczyk M, Massalska D, et al. Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential. Endocrine Reviews. 2026. doi:10.1210/endrev/bnaf043
BibTeX
@article{Ciebiera2026,
author = {Ciebiera, Michał and Zarychta, Elżbieta and Żeber-Lubecka, Natalia and Zgliczyńska, Magdalena and Włodarczyk, Marta and Massalska, Diana and Corachán, Ana and Ali, Mohamed and Madueke-Laveaux, Obianuju Sandra and Al-Hendy, Ayman},
title = {Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential},
journal = {Endocrine Reviews},
year = {2026},
doi = {10.1210/endrev/bnaf043}
}
EUVIMED